More Galleries
Rebirth of America's dead factories Defunct factories around the country are in high demand as U.S. production once again revs up. More
7 hot businesses to start now It's hard to predict what businesses will take off, but these startup ideas have been drawing tons of interest from entrepreneurs and their customers on More
How will a minimum wage hike hit businesses? Thirteen states increased the minimum wage on Jan. 1, and President Obama supports raising the federal rate to $10.10. 4 small business owners weigh in on how an increase would affect them. More

Special Offer
27 of 36
A better endoscope
A better endoscope
Malcolm McVay, Katharine Melzer, Jules Huang, Rory Berry and Sarah Carr
Team name: Perseus Medical Technologies (Fiberview)

School name: UCLA, Anderson School of Management

Team members: Rory Berry, Sarah Carr, Nir Hoftman, Jules Huang, Michael Lee, Aman Mahajan, Malcolm McVay, Katharine Melzer

Concept: Physicians from the UCLA David Geffen School of Medicine have developed an alternative to traditional endoscopes, long, tube-shaped optical viewing instruments that allow doctors to peer inside the body for irritation, ulcers, inflammation and abnormal tissue.

Endoscopic carts, complete with a display monitor, external light source and thermal paper printer, typically cost $30,000 or more. They are difficult to move and have no electronic data storage or information transfer capabilities. By contrast, Perseus's patented "Miniature Fiber Optic Workstation" costs $2,200 a pop. The workstation is portable, using wireless technology and real-time video to store information, manage data, and transfer visuals to operating room monitors.

Though Perseus anticipates competition from established endoscopic equipment manufacturers, it has not found any comparable product on the market. Market research suggests that 53,500 new endoscopic units will be sold in the U.S. in 2009. The global market is roughly twice that size and is expected to grow at a rate of at least 5% a year.

Timeline: Perseus anticipates having a working prototype with FDA approval by March 2009. It projects sales to grow from 1,450 units in 2009 to more than 14,900 units by 2013. - Emily Maltby

NEXT: Electricity from evaporation

Last updated May 02 2008: 11:51 AM ET
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.